# DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications

Study · id `cardio:ct-nct04535050` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04535050](<https://clinicaltrials.gov/study/NCT04535050>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04535050

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT04535050. Randomized; single masking; primary purpose treatment. Start 2022-10-20 (actual); primary completion 2023-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT04535050, source copy `cardio:ctgov-nct04535050-2023-03-20`, retrieved 2026-10-26)
- Started: 2022-10-20 (actual) (ClinicalTrials.gov record NCT04535050, source copy `cardio:ctgov-nct04535050-2023-03-20`, retrieved 2026-10-26)
- Primary completion: 2023-12-30 (anticipated) (ClinicalTrials.gov record NCT04535050, source copy `cardio:ctgov-nct04535050-2023-03-20`, retrieved 2026-10-26)
- Completion: 2026-04-15 (anticipated) (ClinicalTrials.gov record NCT04535050, source copy `cardio:ctgov-nct04535050-2023-03-20`, retrieved 2026-10-26)
- Countries: Greece (ClinicalTrials.gov record NCT04535050, source copy `cardio:ctgov-nct04535050-2023-03-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04535050-2023-03-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications
- Condition: Hypertension
- Condition: Vascular Diseases
- Condition: Cardiovascular Diseases
- Intervention (Device): Renal denervation
- Intervention (Procedure): Renal angiography
- Lead sponsor: Kalos Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 0281187e374dfb34e8a0317412903fd477881d0b5890e01c9a9d2e4d2c61694d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
